The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
In this systematic review the analysis of hypoglycemia and cardio-vascular events was analyzed due to therapy by SU and other secretagenes. Accordingto more then 1400 publications from 1984 to 2009 there is no clear data of increasing hypoglycemia and cardio-vascular events by using micronisedgliben...
Guardado en:
Autores principales: | Aleksey Vadimovich Zilov, Tatiana Borisovna Morgunova, Anna Leont'evna Terekhova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7ec271ede7342faab2619f66c0a7901 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
por: Alla Vsevolodovna Rudakova
Publicado: (2011) -
Arrhythmogenic effects of hypoglycemia
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2012) -
Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
por: Andrey Olegovich Emel'yanov, et al.
Publicado: (2009) -
Leading causes of death and concomitant pathology in patients with type 2 diabetes mellitus according to autopsy data
por: Anna Leont'evna Terekhova, et al.
Publicado: (2011) -
Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
por: Lyudmila Viktorovna Nedosugova
Publicado: (2013)